IDYA
Price
$22.10
Change
+$0.18 (+0.82%)
Updated
Jul 3 closing price
Capitalization
1.94B
36 days until earnings call
STOK
Price
$11.63
Change
+$0.15 (+1.31%)
Updated
Jul 7, 01:49 PM (EDT)
Capitalization
626.77M
35 days until earnings call
Interact to see
Advertisement

IDYA vs STOK

Header iconIDYA vs STOK Comparison
Open Charts IDYA vs STOKBanner chart's image
IDEAYA Biosciences
Price$22.10
Change+$0.18 (+0.82%)
Volume$522.89K
Capitalization1.94B
Stoke Therapeutics
Price$11.63
Change+$0.15 (+1.31%)
Volume$1K
Capitalization626.77M
IDYA vs STOK Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. STOK commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and STOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (IDYA: $22.10 vs. STOK: $11.48)
Brand notoriety: IDYA and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 43% vs. STOK: 30%
Market capitalization -- IDYA: $1.94B vs. STOK: $626.77M
IDYA [@Biotechnology] is valued at $1.94B. STOK’s [@Biotechnology] market capitalization is $626.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 2 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 3 bearish.
  • STOK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than STOK.

Price Growth

IDYA (@Biotechnology) experienced а -0.85% price change this week, while STOK (@Biotechnology) price change was -3.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.53%. For the same industry, the average monthly price growth was +13.90%, and the average quarterly price growth was -0.51%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+5.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.94B) has a higher market cap than STOK($627M). STOK YTD gains are higher at: 4.080 vs. IDYA (-14.008). STOK has higher annual earnings (EBITDA): 40.3M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. STOK (357M). STOK has less debt than IDYA: STOK (2.35M) vs IDYA (26M). STOK has higher revenues than IDYA: STOK (191M) vs IDYA (7M).
IDYASTOKIDYA / STOK
Capitalization1.94B627M309%
EBITDA-356.46M40.3M-885%
Gain YTD-14.0084.080-343%
P/E RatioN/A14.00-
Revenue7M191M4%
Total Cash693M357M194%
Total Debt26M2.35M1,106%
FUNDAMENTALS RATINGS
IDYA vs STOK: Fundamental Ratings
IDYA
STOK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9441
PRICE GROWTH RATING
1..100
5240
P/E GROWTH RATING
1..100
10033
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STOK's Valuation (52) in the null industry is in the same range as IDYA (62). This means that STOK’s stock grew similarly to IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for STOK (100). This means that IDYA’s stock grew somewhat faster than STOK’s over the last 12 months.

STOK's SMR Rating (41) in the null industry is somewhat better than the same rating for IDYA (94). This means that STOK’s stock grew somewhat faster than IDYA’s over the last 12 months.

STOK's Price Growth Rating (40) in the null industry is in the same range as IDYA (52). This means that STOK’s stock grew similarly to IDYA’s over the last 12 months.

STOK's P/E Growth Rating (33) in the null industry is significantly better than the same rating for IDYA (100). This means that STOK’s stock grew significantly faster than IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYASTOK
RSI
ODDS (%)
Bearish Trend 5 days ago
63%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
72%
Bearish Trend 5 days ago
89%
Momentum
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
83%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRGTX99.411.41
+1.44%
Virtus Zevenbergen Technology Inst
ITHRX51.720.40
+0.78%
Hartford Capital Appreciation R3
VYMYX20.030.15
+0.75%
Voya Mid Cap Research Enhanced Index W
IPEAX6.130.04
+0.66%
Voya Large Cap Value Port A
RYLVX110.890.21
+0.19%
Rydex S&P 500 Pure Value A

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.82%
IMNM - IDYA
60%
Loosely correlated
+2.43%
CGON - IDYA
60%
Loosely correlated
+0.82%
NRIX - IDYA
59%
Loosely correlated
+2.33%
DNLI - IDYA
56%
Loosely correlated
-1.41%
XENE - IDYA
56%
Loosely correlated
-0.33%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-0.61%
IDYA - STOK
53%
Loosely correlated
+0.82%
NRIX - STOK
52%
Loosely correlated
+2.33%
IMNM - STOK
51%
Loosely correlated
+2.43%
RNA - STOK
50%
Loosely correlated
-0.65%
DNLI - STOK
50%
Loosely correlated
-1.41%
More